This result indicates that rAAV-P2 treatment can effectively inhibit the progression of TNBC, whereas the infection of rAAV-DIO-GSDMDNT cannot initiate the expression of GSDMDNT in the tumor cells. This evidence concerns the gene GSDMD and neoplasm.